"Hormones" Endocrinology Health & Wellnes Clinic

14/12/2025

https://youtu.be/3NlgIeQ4x4E?si=Nf9-CYOHZZT7ztR5

Hoy en día la tecnología está ayudando a la gente a manejar mejor sus problemas de salud, especialmente condiciones como la diabetes 💡. Porque una cosa es q...

12/12/2025

28/10/2022

27/10/2022

En serio que le ponen esto a los paciente y le cobran 300 dólares semanales? Cómo está el médico de pacotilla buscón!

27/10/2022

03/06/2020

https://www.endomd.com/new/homepage.php

05/02/2020

January can be a tough month for our diabetic patients. Deductibles start over, insurance may be new, drug formularies change every year, etc, etc. We share the frustration with you. 😩. Most Endos (and their staff) spend an average of an hour or more a day just trying to figure out what medication or device will be covered, what needs a prior authorization, what will be covered but too expensive or simply what will never be covered. While we try our best to help figure this out, we want you to understand your insurance. 📌Spend a couple of hours reviewing what plan you signed up for. 📌Figure out how to get to your insurance’s drug formulary. (Most of this is now online through your insurance login). 📌Consider bringing in a copy of the formulary for diabetic drugs so that we can more easily choose the preferred medication. 📌Schedule your follow up before your refill is due so that any changes can be discussed in person. 📌Be patient with your Endo. Our patients have hundreds of various insurance plans and we have no way of knowing what yours will cover. This is work we are having to take care of after we are done seeing patients, finishing notes, reviewing labs, etc. We don’t get paid for this time but we do it so that our patients can get the treatment they need. 📌Do your part by understanding your insurance and being proactive about the details. .illuris.pantry

05/02/2020

01/09/2019

AACE Continuing Education

31/07/2019

AACE Continuing Education

24/07/2019

On Thursday, the Food and Drug Administration approved Eli Lilly and Company's Baqsimi, a non-injectable, nasal glucagon and the first of its kind.